Jove
Visualize
Contáctanos

Videos de Conceptos Relacionados

Chronic Kidney Disease II: Clinical Manifestations01:24

Chronic Kidney Disease II: Clinical Manifestations

520
Chronic Kidney Disease (CKD) progressively impairs multiple body systems due to the accumulation of uremic toxins, which disrupt cellular functions across various organs.Neurologic symptomsNeurologic symptoms often arise early in CKD, as uremic toxin buildup drives changes in cognitive and motor functions. Patients frequently experience fatigue, headache, confusion, difficulty concentrating, and, in severe cases, seizures. Peripheral neuropathy commonly manifests as burning sensations in the...
520
Coronary Artery Disease III: Clinical Manifestations01:30

Coronary Artery Disease III: Clinical Manifestations

299
Coronary Artery Disease (CAD) is a primary health risk worldwide, leading to significant morbidity and mortality. The condition arises from the buildup of atherosclerotic plaques within the coronary arteries, resulting in diminished blood supply to the heart muscle.The clinical manifestations of CAD vary widely, from asymptomatic stages to severe, life-threatening conditions. Understanding these manifestations is crucial for early diagnosis and effective management.Angina Pectoris: The Warning...
299
Endocarditis II: Clinical Features of Infective Endocarditis01:25

Endocarditis II: Clinical Features of Infective Endocarditis

364
Endocarditis can present various clinical features depending on the causative organism and the patient's underlying health conditions. Initially, the clinical features of infective endocarditis develop gradually, presenting with nonspecific symptoms that can be easily mistaken for other illnesses.General SymptomsEarly symptoms of infective endocarditis are fever, chills, weakness, malaise, fatigue, and weight loss. These symptoms reflect the systemic nature of the infection and the body's...
364
Heart Failure III: Clinical Manifestations01:26

Heart Failure III: Clinical Manifestations

436
Heart failure (HF) manifests primarily as dyspnea, fatigue, and fluid retention, resulting in peripheral and pulmonary edema. Symptoms may vary depending on which ventricle is more affected, left or right.Left-Sided Heart FailureAlso known as left ventricular failure, this condition results from the left ventricle's inability to fill or eject sufficient blood into the systemic circulation. It leads to pulmonary congestion, which occurs when the left ventricle fails to eject blood effectively...
436
Gastroesophageal Reflux Disease II: Clinical Features and Management01:29

Gastroesophageal Reflux Disease II: Clinical Features and Management

652
Gastroesophageal reflux disease, or GERD, is a persistent medical condition that affects many individuals worldwide. Its clinical manifestations can vary greatly, making diagnosis and management challenging for healthcare professionals. The following is a comprehensive overview of the clinical manifestations, assessment, and management strategies for GERD.
Clinical Manifestations
GERD presents itself in a multitude of ways, with symptoms varying from person to person. The hallmark symptoms are...
652
Hypertension III: Clinical Manifestations and Diagnostic Studies01:30

Hypertension III: Clinical Manifestations and Diagnostic Studies

437
Hypertension is asymptomatic and also referred to as the "silent killer" until it progresses to a severe stage or causes target organ disease. Patients may experience symptoms stemming from the strain on blood vessels and tissues in various organs or the heart's increased workload.Physical exams might show no abnormalities other than high blood pressure. Signs of vascular damage, when present, correspond to the organs supplied by the affected vessels, leading to target organ damage. For...
437

También podría leer

Artículos Relacionados

Artículos vinculados a este trabajo por autores compartidos, revista y gráfico de citas.

Ordenar por
Same author

"Utterly Overwhelming"-A Mixed-Methods Exploration of Sensory Processing Differences and Mental Health Experiences in Middle-Aged and Older Autistic Adults.

Autism in adulthood·2026
Same author

Developmental Trajectories of Adaptive Behavior from Toddlerhood to Middle Adulthood in Autism.

Autism in adulthood·2026
Same author

Understanding Timing of Autism Diagnosis: Impact of Sociodemographic Factors, Verbal Ability, and Sex.

medRxiv : the preprint server for health sciences·2026
Same author

Longitudinal Association Between Social Support and Quality of Life Among Middle-Aged and Older Autistic Adults.

Autism : the international journal of research and practice·2026
Same author

Understanding the impact of prior depressive and anxiety symptoms and autism diagnosis on menopause symptoms.

Women's health (London, England)·2026
Same author

Executive function challenges persist into young adulthood and predict mental health outcomes in autism.

Journal of child psychology and psychiatry, and allied disciplines·2026
Same journal

Patient-derived forebrain cortical organoids reveal biphasic tau-MAP6-microtubule axis dysfunction in tauopathy.

Alzheimer's & dementia : the journal of the Alzheimer's Association·2026
Same journal

Genetic architecture of the limbic white matter microstructure in aging and Alzheimer's Disease.

Alzheimer's & dementia : the journal of the Alzheimer's Association·2026
Same journal

Greater choroid plexus volume is linked to poor sleep, neurodegeneration, and cognitive deficits in older adults: Evidence from the IGNITE Study.

Alzheimer's & dementia : the journal of the Alzheimer's Association·2026
Same journal

Plasma-based neurobiological protein biomarkers as predictors of dementia progression: Insights from longitudinal aging study in India - Diagnostic assessment of dementia.

Alzheimer's & dementia : the journal of the Alzheimer's Association·2026
Same journal

Neuropathology-specific language features in primary progressive aphasia.

Alzheimer's & dementia : the journal of the Alzheimer's Association·2026
Same journal

Dementia blood biomarkers in the context of post-stroke cognitive outcomes: Systematic review and evidence synthesis.

Alzheimer's & dementia : the journal of the Alzheimer's Association·2026
Ver todos los artículos relacionados
JoVE
x logofacebook logolinkedin logoyoutube logo
ACERCA DE JoVE
Visión GeneralLiderazgoBlogCentro de Ayuda JoVE
AUTORES
Proceso de PublicaciónConsejo EditorialAlcance y PolíticasRevisión por ParesPreguntas FrecuentesEnviar
BIBLIOTECARIOS
TestimoniosSuscripcionesAccesoRecursosConsejo Asesor de BibliotecasPreguntas Frecuentes
INVESTIGACIÓN
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchivo
EDUCACIÓN
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualCentro de Recursos para ProfesoresSitio de Profesores
Términos y Condiciones de Uso
Política de Privacidad
Políticas

Video Experimental Relacionado

Updated: Jan 7, 2026

A Metadata Extraction Approach for Clinical Case Reports to Enable Advanced Understanding of Biomedical Concepts
07:50

A Metadata Extraction Approach for Clinical Case Reports to Enable Advanced Understanding of Biomedical Concepts

Published on: September 20, 2018

16.4K

Manifestaciones Clínicas

Gregory L Wallace1, Goldie A McQuaid2, Sean C Duane3

  • 1The George Washington University, Washington D.C., DC, USA.

Alzheimer's & dementia : the journal of the Alzheimer's Association
|December 25, 2025
PubMed
Resumen
Este resumen es generado por máquina.

Los adultos autistas muestran un mayor riesgo de deterioro cognitivo, a menudo relacionado con el uso de medicamentos anticolinérgicos. Este estudio destaca la necesidad de una gestión cuidadosa de la medicación en las poblaciones autistas para mitigar el riesgo de demencia.

Palabras clave:
deterioro cognitivoautismomedicamentos anticolinérgicosdemenciagestión de la medicación

Más Videos Relacionados

Imaging Features of Systemic Sclerosis-Associated Interstitial Lung Disease
04:44

Imaging Features of Systemic Sclerosis-Associated Interstitial Lung Disease

Published on: June 16, 2020

20.7K
Isolating Human Peripheral Blood Mononuclear Cells and CD4+ T cells from Sézary Syndrome Patients for Transcriptomic Profiling
09:08

Isolating Human Peripheral Blood Mononuclear Cells and CD4+ T cells from Sézary Syndrome Patients for Transcriptomic Profiling

Published on: October 14, 2021

6.1K

Videos de Experimentos Relacionados

Last Updated: Jan 7, 2026

A Metadata Extraction Approach for Clinical Case Reports to Enable Advanced Understanding of Biomedical Concepts
07:50

A Metadata Extraction Approach for Clinical Case Reports to Enable Advanced Understanding of Biomedical Concepts

Published on: September 20, 2018

16.4K
Imaging Features of Systemic Sclerosis-Associated Interstitial Lung Disease
04:44

Imaging Features of Systemic Sclerosis-Associated Interstitial Lung Disease

Published on: June 16, 2020

20.7K
Isolating Human Peripheral Blood Mononuclear Cells and CD4+ T cells from Sézary Syndrome Patients for Transcriptomic Profiling
09:08

Isolating Human Peripheral Blood Mononuclear Cells and CD4+ T cells from Sézary Syndrome Patients for Transcriptomic Profiling

Published on: October 14, 2021

6.1K

Área de la Ciencia:

  • Neurociencia; Gerontología; Investigación sobre el Autismo

Sus antecedentes:

  • Los datos de reclamaciones de atención médica sugieren que los adultos autistas tienen tasas más altas de diagnósticos relacionados con la demencia. Faltan datos prospectivos sobre el riesgo de deterioro cognitivo y los cribados de demencia en adultos autistas. La alta polifarmacia en adultos autistas puede conducir a una carga anticolinérgica significativa, un factor de riesgo conocido para la demencia.

Objetivo del estudio:

  • Evaluar el riesgo de deterioro cognitivo en adultos autistas utilizando cribados de demencia. Documentar la carga de medicación anticolinérgica en adultos autistas. Investigar la asociación entre el deterioro cognitivo y la carga anticolinérgica en adultos autistas.

Principales métodos:

  • Se reclutaron dos muestras de adultos autistas a través de SPARK: 210 'independientes' (edad 42-81) y 500 'dependientes' (edad 18-68). El deterioro cognitivo se evaluó utilizando el AD8 (autoevaluado) para adultos independientes y el DSQIID (evaluado por el cuidador) para adultos dependientes. El uso de medicamentos anticolinérgicos se cuantificó utilizando la Escala de Carga Anticolinérgica CRIDECO (CALS).

Principales resultados:

  • El 30% de los adultos autistas independientes y el 10-3% de los adultos autistas dependientes mostraron resultados positivos en el cribado de deterioro cognitivo. Más del 63% de los participantes en ambas muestras utilizaron al menos un medicamento anticolinérgico. Una mayor potencia anticolinérgica se asoció significativamente con un aumento en las calificaciones de deterioro cognitivo en ambas muestras (p < .01).

Conclusiones:

  • Los cribados de demencia confirman informes comunes de deterioro cognitivo en adultos autistas, alineándose con los datos de reclamaciones. Los adultos autistas exhiben altas tasas de uso de medicamentos anticolinérgicos. Una mayor potencia anticolinérgica se relaciona con informes de deterioro cognitivo en adultos autistas, potencialmente a edades más tempranas que en la población general.